U.S. Healthcare Services Stock News

United Natural Foods stock: recent return profile and fundamentals United Natural Foods (UNFI) has drawn investor attention after a period of mixed short term returns, including a 1% decline over the past day and a 6.6% gain over the past week. See our latest analysis for United Natural Foods. That 6.6% 7 day share price return sits within a stronger trend, with a 90 day share price return of 23% and a 1 year total shareholder return of 52%, hinting at improving sentiment and a reassessment...

What stands out about Sysco right now? Sysco (SYY) has been drawing attention after its recent share performance, with the stock near US$84.91 and returns over the past year and past 3 months catching many investors’ eyes. See our latest analysis for Sysco. At around US$84.91, Sysco’s recent 90 day share price return of 14.22% and 1 year total shareholder return of 20.13% point to momentum that has built over a longer stretch, even with some short term share price softness. If Sysco’s move...

Furstenau Financial, a large wealth advisory team, has left LPL Financial Holdings for Carson Group, taking its client relationships to a rival platform. At the same time, LPL has added Legacy Ridge Private Wealth as a new independent practice through its Strategic Wealth model. These moves highlight both competitive pressures on LPL’s advisor network and the firm’s efforts to attract and support new practices. For investors watching LPL Financial Holdings (NasdaqGS:LPLA), these advisor...

Are you wondering if Rockwell Automation is fairly priced at around US$358 a share, or if the recent moves have opened up a better entry point for you? The stock has seen mixed returns recently, with a 5.4% decline over the last 7 days and a 13.2% decline over the last 30 days, even though the 1 year return sits at 42.5% and the 5 year return at 49.8%. These moves have kept Rockwell Automation on many investors' watchlists, as the pullback over the past month contrasts with its longer term...

If you are wondering whether Rubrik's current share price lines up with its underlying worth, you are not alone. This article is built to help you weigh what you are paying against what you are getting. Rubrik recently closed at US$54.02, with returns of a 3.3% decline over the past week, a 3.2% decline over the past month, and a 28.4% decline year to date, while the 1 year return sits at a 2.3% decline. Recent coverage of Rubrik has focused on its positioning in the data security and backup...

Wondering if Waters' current share price really matches what the business is worth, or if the market is mispricing it right now. The stock last closed at US$283.32, with returns of a 10.2% decline over 7 days, a 13.4% decline over 30 days, a 25.8% decline year to date, a 22.3% decline over 1 year, a 7.8% decline over 3 years and a 5.4% gain over 5 years. Recent news has largely focused on Waters' role in life sciences tools and analytical instruments, which can shape how investors think...

Recent performance snapshot Expedia Group (EXPE) has been under pressure recently, with the stock showing a 1-day return of -1.17% and a 9.50% decline over the past week, drawing fresh attention from investors. See our latest analysis for Expedia Group. While Expedia Group's 1-day and 7-day share price returns of 1.17% and 9.50% declines show recent selling pressure, the current share price of US$227.65 sits against a weaker year to date share price return of 19.54%, even as the 1-year total...

Exelixis (EXEL) is back on investor radars after six analysts raised their earnings forecasts for fiscal 2026, citing the company’s oncology pipeline and their growth expectations as key reasons for the revised outlook. See our latest analysis for Exelixis. Even with the recent analyst optimism, Exelixis’ shares have cooled slightly, with a 30 day share price return of a 4.21% decline and a year to date share price return of a 5.53% decline. At the same time, the 1 year total shareholder...

Why Viatris (VTRS) Is On Investors’ Radar Today Viatris (VTRS) has drawn fresh attention after recent share price moves, including a 1 day return of about 1% decline and a month performance around 13% decline, prompting closer inspection of its fundamentals. See our latest analysis for Viatris. At a share price of US$13.80, Viatris has recently given back some ground with a 7 day share price return of about 5% decline and a 30 day share price return of around 13% decline. Its 1 year total...

The Morning Bull - US Market Morning Update Friday, Mar, 13 2026 US stock futures are pointing lower this morning, with E-mini S&P 500 contracts down about 0.2%, as investors react to a fresh jump in government bond yields and renewed energy worries. The US 10 year yield is around 4.26%, which makes borrowing more expensive and can pressure valuations for growth focused companies. At the same time, commodity futures are higher and the US is weighing a temporary shipping rule waiver to ease an...

CleanSpark (CLSK) has been on many watchlists after a mixed return profile, with a loss over the past 3 months but a positive 1 year total return, and revenue paired with a net loss. See our latest analysis for CleanSpark. The 1 year total shareholder return of 19.82% contrasts sharply with a 90 day share price return decline of 31.93%. This suggests momentum has cooled recently even as longer term holders remain ahead overall. If CleanSpark’s recent swings have you thinking about other...

Why Verra Mobility Is On Investors’ Radar Today Verra Mobility (VRRM) has seen pressure on its share price in recent months, with negative returns over the past month, past 3 months, year to date, and the past year putting recent performance in focus for investors. See our latest analysis for Verra Mobility. With the share price at US$15.16 and a 30 day share price return of an 18.8% decline, Verra Mobility’s momentum has been fading, and its 1 year total shareholder return of a 24.95%...

In March 2026, Alamo Group Inc. reported fourth-quarter 2025 sales of US$373.65 million and net income of US$15.51 million, both down from the prior year, with full-year earnings per share from continuing operations also lower than in 2024. Management described 2025 as a transitional year involving restructuring and sharper priorities, while the company missed analyst expectations and posted the weakest performance versus estimates in its agricultural machinery peer group. Against this...

If you are wondering whether Mattel's current share price reflects its true worth, this article will walk through what the numbers are saying about the stock's value. Mattel recently closed at US$16.22, with returns of 1.2% over 7 days, a 23.0% decline over 30 days, and year to date and 1 year returns of 19.1% and 17.5% declines respectively. These moves may have shifted how the market views both its potential and its risks. Recent coverage around Mattel has focused on its position in the...

If you are wondering whether Hecla Mining's share price still reflects its underlying value after a strong run, this article walks through what the numbers are actually saying about the stock. The shares last closed at US$20.53, with returns of a 1.3% decline over the past week, a 10.7% decline over the past month, gains of 8.8% year to date, 256.4% over the last year, 286.1% over three years, and 216.6% over five years. Recent headlines around Hecla Mining have focused on the company as a...

Gartner (IT) is back in focus after several plaintiff law firms opened investigations into its recent earnings disclosures, particularly the use of non GAAP metrics and the realism of its earnings guidance. See our latest analysis for Gartner. Those investigations and cautious reactions to Gartner’s 2026 outlook have come alongside sharp share price pressure, with a 90 day share price return of 31.34% decline and a 1 year total shareholder return of 64.48% decline, suggesting momentum has...

Moody's (NYSE:MCO) has issued a warning on the growing risks in complex structured private credit transactions. The firm highlights hidden liabilities and unrecognized future obligations that may not appear in standard credit metrics. Moody's is urging lenders, investors and insurers to adopt a more holistic approach to assessing credit risk across these structures. Moody's, trading at $426.47, is calling attention to structured private credit deals that are increasingly used by investment...

Recent filings show Mario Gabelli and GAMCO Investors increasing their positions in Madison Square Garden Sports (MSGS), highlighting the New York Knicks and Rangers as core assets that some investors view as potentially undervalued opportunities. See our latest analysis for Madison Square Garden Sports. At a share price of $312.31, Madison Square Garden Sports has given investors a 31.53% 3 month share price return and a 68.13% 1 year total shareholder return, suggesting momentum has been...

Why Cognex may be on your radar now Cognex (CGNX) has drawn attention after a mixed stretch in the share price, with a small pullback over the past week following gains over the past month and the past 3 months. See our latest analysis for Cognex. At a share price of US$48.77, Cognex has given investors a 36.8% 90 day share price return and a 62.47% 1 year total shareholder return, which signals building momentum despite the recent 1 day and 7 day pullback. If Cognex's recent move has you...

Allstate (ALL) is back in focus after recent share moves, with the stock closing at $205.03. Investors are weighing this price against the insurer’s earnings profile and its current value score of 5. See our latest analysis for Allstate. Recent trading has been a bit choppy, with a 7 day share price return of 3.11% and a 90 day share price return of 1.04%. At the same time, Allstate’s 3 year total shareholder return of 95.84% and 5 year total shareholder return of 99.35% reflect a very strong...

Corvus Pharmaceuticals has moved its lead candidate, soquelitinib, into late-stage Phase 3 and Phase 2 trials across several indications. The company raised $189 million in a follow-on offering, which it says extends its cash runway into 2028. Corvus Pharmaceuticals (NasdaqGM:CRVS) is drawing attention after pushing soquelitinib into more advanced clinical trials while securing fresh capital to support the work. The stock trades at $16.01, with very large 3-year and 1-year returns, and a...

Why EHang’s latest earnings matter for shareholders EHang Holdings (NasdaqGM:EH) just reported its Q4 and full year 2025 results, highlighted by a move to net income in the quarter after a net loss in the prior year period. Fourth quarter sales were CNY 243.78 million compared with CNY 164.28 million a year earlier, with net income of CNY 10.49 million replacing a CNY 46.86 million net loss, and basic earnings per share reaching CNY 0.14. See our latest analysis for EHang Holdings. The share...

In early March 2026, DigitalOcean announced that Workato’s AI Research Lab had shifted its next-generation enterprise AI agents to DigitalOcean’s vertically integrated, inference-optimized platform powered by NVIDIA Hopper GPUs, achieving faster time-to-first-token, higher throughput, and lower costs for complex, reasoning-heavy workloads like Llama-3.3-70B under real production conditions. By co-designing a distributed inference architecture on DigitalOcean Kubernetes and using NVIDIA...

Boeing (NYSE:BA) has secured a new $289 million contract to supply up to 5,000 precision guided bombs to Israel. The deal arrives as Boeing faces fresh delivery delays tied to 737 MAX wiring issues in its commercial aircraft segment. This order adds to Boeing's defense backlog at a time when investors are closely watching the split between its military and commercial businesses. Boeing shares recently closed at $204.76, with the stock down 7.8% over the past week and 15.6% over the past...